|
|
-
8th IAS Conference on HIV Pathogenesis, Treatment and Prevention*
July 19-22, 2015
| Vancouver, Canada
CCO is the official provider of online scientific analysis for the 2015 International AIDS Society meeting, through Capsule Summaries, downloadable slides, and CME-certified faculty analysis of key studies.
-
In this Expert Analysis, Andrew Carr, MBBS, MD, FRACP, FRCPA; Joel E. Gallant, MD, MPH; and Anton L. Pozniak, MD, FRCP, provide a comprehensive review of key data on the prevention and management of HIV infection presented at the 8th Conference of the International AIDS Society.
-
In this downloadable slideset, Andrew Carr, MBBS, MD, FRACP, FRCPA; Joel E. Gallant, MD, MPH; and Anton L. Pozniak, MD, FRCP, review key studies presented at the 2015 International AIDS Society conference.
-
Here is my take on the most anticipated studies that will be presented in Vancouver this year.
Latest Content
-
In this Expert Analysis, Andrew Carr, MBBS, MD, FRACP, FRCPA; Joel E. Gallant, MD, MPH; and Anton L. Pozniak, MD, FRCP, provide a comprehensive review of key data on the prevention and management of HIV infection presented at the 8th Conference of the International AIDS Society.
Faculty: Andrew Carr MBBS, MD, FRACP, FRCPA, Joel E. Gallant MD, MPH, Anton L. Pozniak MD, FRCP
Released: 9/28/2015
-
| Jürgen K. Rockstroh MD - 9/8/2015 |
2 comments / Last Comment: 12/12/2015 |
My summary of new and noteworthy data on managing HCV/HIV coinfection from IAS 2015.
-
In this downloadable slideset, Andrew Carr, MBBS, MD, FRACP, FRCPA; Joel E. Gallant, MD, MPH; and Anton L. Pozniak, MD, FRCP, review key studies presented at the 2015 International AIDS Society conference.
Date Posted: 8/4/2015
-
However, all 3 cases of virologic rebound and 1 case of central nervous system escape occurred in the monotherapy switch arm.
Date Posted: 7/28/2015
-
Black MSM had the lowest adherence levels across the study and a sharp drop off in adherence occurred among all participants between Week 12 and Week 24, corresponding to a reduced frequency of study visits beginning at Week 12.
Date Posted: 7/28/2015
-
A low CD4+ cell count was also significantly associated with differences in hip bone mineral density changes.
Date Posted: 7/27/2015
-
Week 24 virologic and immunologic outcomes were similar between arms; doravirine was associated with fewer CNS adverse events vs efavirenz.
Date Posted: 7/27/2015
-
Treatment generally well tolerated with evidence of improvements in markers of HBV and liver disease in this coinfected population.
Date Posted: 7/26/2015
-
SVR12 rates with grazoprevir/elbasvir in HCV/HIV-coinfected patients comparable to those of HCV-monoinfected patients with no impact on HIV disease or serious treatment-related adverse events.
Date Posted: 7/26/2015
-
Discontinuation rates due to toxicity significantly lower with lower atazanavir/ritonavir dose.
Date Posted: 7/24/2015
Conference News – Reported by NAM
|
|
|
Click here for more news reports and to learn more about NAM. |
|
Partnership Information
|
|
IAS 2015 conference organizers are using a blog and other social media to communicate with delegates attending the meeting and with those following the conference from home.
Social Media
IAS 2015 updates are available at Facebook, Twitter, YouTube, and SmugMug.
For more information about these resources and IAS 2015, go to www.ias2015.org.
|
www.aidsmap.com provides comprehensive news coverage of IAS 2015, with news reports each day and a daily summary email bulletin for those who want just the highlights of the meeting.
To view the daily news coverage, and to sign up for the daily highlights bulletin (also available in French, Italian, Malay, Portuguese, Spanish, and Russian) go to www.aidsmap.com/ias2015. |
|
|
|